ConCallIQ
Go Pro
SBILIFE Diversified 27 Oct 2023

SBI Life Insurance Company Limited — Q2 FY24

SBI Life delivered a strong H1 FY24 with PAT up 19% YoY to INR 7.6B, driven by 24% growth in new business premium to INR 162.6B and private market leadership at 24.7% share.

bullish high
Compare with...
Revenue
EBITDA
PAT ₹760 Cr +19%
EBITDA Margin
Duration
Read Time 1 min read

Financial stats pending filing verification

2-Minute Summary

✦ AI-Generated from Full Transcript

SBI Life delivered a strong H1 FY24 with PAT up 19% YoY to INR 7.6B, driven by 24% growth in new business premium to INR 162.6B and private market leadership at 24.7% share. Individual APE grew 17% to INR 71.4B, aided by robust agency expansion (33% agent growth) and ULIP demand. VoNB margin held steady at 28.6% despite higher ULIP mix, supported by repricing of non-par and annuity products. Management reaffirmed 20% full-year individual APE growth guidance, with focus on maintaining a 55/45 ULIP/non-ULIP mix. Key risks include equity market volatility impacting ULIP sales and potential margin pressure from rising commission costs under new IRDAI norms.

Promises0 met · 2 missedRisks3 trackedTranscriptfull text
Research workspace

Focused Modules

Promises 2 promises

Promise Tracker

0 delivered, 0 close, 2 missed.

View Promises →
!Risks 3 risks

Risk Intelligence

Equity market volatility impacting ULIP sales

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Private Market Share (Individual NBP) 27.3%
+169bps YoY

Gained 169 bps market share in individual new business premium, maintaining leadership.

13-Month Persistency 85.4%
Not specified

Persistency remained strong; 49-month and 61-month persistency improved by 92 bps and 509 bps respectively.

Agency Channel Growth (Individual APE) 35%
+35% YoY

Agency channel individual APE grew 35% YoY, driven by agent additions and productivity gains.

Assets Under Management (AUM) INR 3,451.5B
+22% YoY

AUM grew 22% YoY to INR 3.45 trillion, reflecting strong investment performance and inflows.

What Changed vs Last Quarter

Comparing Q2 FY24 vs Q1 FY24
3 new guidance3 dropped3 new risk3 risk resolved
NEW
Full-year individual APE growth of ~20%

Management reaffirmed 20% growth guidance for FY24 individual APE, despite H1 growth of 17%.

NEW
VoNB margin in 28%-30% range

VoNB margin expected to remain within 28%-30% for FY24, supported by product mix and repricing actions.

NEW
Target ULIP/non-ULIP mix of 55/45

Management aims to achieve a 55/45 product mix between ULIP and non-ULIP, though market conditions may influence near-term mix.

DROPPED
FY24 growth aspiration of 20-25%

Management expects to deliver better than industry growth, targeting 20-25% growth in individual rated premium for FY24.

DROPPED
VNB margin to remain range-bound around 28-30%

Management expects VNB margins to stay in the 28-30% range, with no significant expansion or compression expected.

DROPPED
Non-par share expected at 24-25% of business

CFO indicated non-par share should normalize to around 24-25% of business for the full year, similar to FY23.

NEW RISK
Equity market volatility impacting ULIP sales

A sharp market downturn could reduce ULIP demand, affecting growth and product mix targets.

NEW RISK
Rising commission costs under new IRDAI norms

New commission guidelines may increase payout ratios, pressuring margins if not offset by mix changes.

NEW RISK
Reinsurance support for protection business

While improving, reinsurance terms remain cautious; slower normalization could cap protection growth.

RISK GONE
Potential margin pressure from increased distributor commissions

Regulatory changes (EOM guidelines) may lead to higher commission payouts, especially to SBI, potentially compressing VNB margins.

RISK GONE
Persistency decline in near-term cohorts

13-month and 25-month persistency dipped slightly, which could impact future renewal premiums and embedded value if not reversed.

RISK GONE
High base effect may constrain growth in coming quarters

Last year's exceptional Q1 growth (86% in individual rated) creates a high base; sustaining 20%+ growth for the full year requires strong performance in subsequent quarters.

Fast read

Guidance and risk preview

Top guidance Full-year individual APE growth of ~20%

Management reaffirmed 20% growth guidance for FY24 individual APE, despite H1 growth of 17%.

Top risk Equity market volatility impacting ULIP sales

A sharp market downturn could reduce ULIP demand, affecting growth and product mix targets.

View Risks →